Pws Conference
11 IND-Enabling Safety Studies for Rare Diseases Timothy J. McGovern, Ph.D. ODE II Associate Director for Pharmacology/Toxicology September 16, 2014 1.
MICHELLE, MULTIPLE SCLEROSIS This is Genzyme Brant, THYROID CANCER Veronica, GAUCHER DISEASE Erik, FH Jimena, MPS I Fida, POMPE DISEASE Genzyme has pioneered.
The Inverted Triangle
